Companies /Healthcare

Inovio Pharmaceuticals Inc

NASDAQ: INO Biotechnology
$1.26
▼ $0.04 (−3.08%) today
Markets closed · 4:41pm ET
Today · % change

Fundamentals

Market Cap
$134.4M
EPS (TTM)
$-1.05
52-Week Range
$1 – $3
Street Target
$3.17

About Inovio Pharmaceuticals

Inovio Pharmaceuticals Inc is a biotechnology firm dedicated to creating DNA-based medicines for various diseases, including those linked to human papillomavirus (HPV), cancer, and infectious diseases. Their innovative approach involves designing DNA sequences to target specific antigens and using CELLECTRA devices for efficient delivery. With a focus on clinical studies, Inovio is advancing treatments for HPV-related conditions and diseases like Ebola and lassa fever. Founded in 1983 and based in Plymouth Meeting, Pennsylvania, Inovio collaborates with numerous global partners to push the boundaries of DNA medicine.

INO Coverage

11:32am ET
Health and Healthcare

Why This Capital Injection Is Huge for Inovio

Inovio Pharmaceuticals has announced that it received $71 million in funding from the U.S. Department of Defense to support the production of its delivery device for the COVID-19 vaccine.

INO
Chris Lange
10:11am ET
Health and Healthcare

How Coronavirus Stocks Are Holding Up

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.

Chris Lange